The present invention provides a process of screening patients for atopic
dermatitis. The process includes the step of determining, in sera of the
patient, the presence of antibodies against nuclear antigens such as
transcription co-activator p75, wherein the presence of such antibodies
indicates atopic dermatitis. The screening process can be used to detect
atopic dermatitis in patients suffering from other conditions such as
asthma or interstitial cystitis.